SCHEMBL5316722

SCHEMBL5316722

CC(C)(C)C(=O)CN1CC2CN(CCNC(=O)CCc3ccc(C#N)cc3)CC(C1)O2

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.43
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
USP14 P54578 4/20 0.37
CD274 Q9NZQ7 1/20 0.36
POLB P06746 2/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ERG P11308 1/20 0.35
CYP2C9 P11712 1/20 0.35
GPBAR1 Q8TDU6 1/20 0.35
DRD2 P14416 6/20 0.35
HTR1A P08908 3/20 0.35
DRD3 P35462 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5316212 0.88 KCNH2 (0.46) KCNH2ALDH1A1GAASMN1; SMN2CD274
SCHEMBL2967576 0.87 KCNH2 (0.47) KCNH2USP14DRD2DRD3
SCHEMBL5314436 0.84 KCNH2 (0.46) KCNH2ALDH1A1GAASMN1; SMN2USP14
SCHEMBL5316942 0.84 LTA4H (0.46) KCNH2ALDH1A1GAASMN1; SMN2HTR1A
SCHEMBL5314550 0.84 CD274 (0.53) KCNH2CD274DRD2DRD3
SCHEMBL2966340 0.84 SIGMAR1 (0.40) KCNH2DRD2HTR1ADRD3
SCHEMBL5320727 0.80 SCN8A (0.45) KCNH2ALDH1A1GAASMN1; SMN2POLB
SCHEMBL2966852 0.79 KCNH2 (0.44) KCNH2KMT2ADRD2DRD3
SCHEMBL4125747 0.78 KCNH2 (0.48) KCNH2CD274GPBAR1DRD2DRD3
SCHEMBL3423966 0.77 SIGMAR1 (0.45) KCNH2DRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007069986-A1 NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS ASTRAZENECA AB (SE) 2007-06-21 WO claimed
WO-2007069986-A1 NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS ASTRAZENECA AB (SE) 2007-06-21 WO disclosed